Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens

被引:37
作者
Chao, NJ [1 ]
Koh, LP [1 ]
Long, GD [1 ]
Gasparetto, C [1 ]
Horwitz, M [1 ]
Morris, A [1 ]
Lassiter, M [1 ]
Sullivan, KM [1 ]
Rizzieri, DA [1 ]
机构
[1] Duke Univ, Ctr Med, Div Cellular Therapy BMT, Durham, NC 27710 USA
关键词
nonmyeloablative conditioning; unrelated cord blood; donor chimerism; survival;
D O I
10.1016/j.bbmt.2004.05.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report the outcome of 13 patients with advanced malignancies who underwent nonmyeloablative conditioning therapy followed by infusion of partially matched unrelated cord blood cells. The median age of these patients was 49 years, and their median weight was 65.7 kg. The median nucleated cell dose infused was 2.07 x 10(7)/kg. Eight of the 13 patients demonstrated donor chimerism between 4 weeks and 6 months, and subsequent conversion to full donor chimerism was achieved in 5 patients. Three patients were alive and free of disease at 158 to 1054 days, with a median survival of 288 days after transplantation. The 100-day event-free survival is 69%, and overall survival is 77%. At 1 year, the event-free and overall survival was 43%. Treatment-related mortality observed within the first 100 days after transplantation was low: 1 previously extensively pretreated patient died of multiorgan failure. This result provides a basis for further exploring this potentially curative approach to selected patients who lack matched related or unrelated hematopoietic stem cell donors. (C) 2004 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:569 / 575
页数:7
相关论文
共 26 条
[1]   Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy [J].
Ballen, KK ;
Becker, PS ;
Emmons, RVB ;
Fitzgerald, TJ ;
Hsieh, CC ;
Liu, Q ;
Heyes, C ;
Clark, Y ;
Levy, W ;
Lambert, JF ;
Chiafari, F ;
Szymanski, I ;
Rososhansky, S ;
Popovsky, MA ;
Stewart, FM ;
Quesenberry, PJ .
BLOOD, 2002, 100 (02) :442-450
[2]   Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning [J].
Barker, JN ;
Weisdorf, DJ ;
DeFor, TE ;
Blazar, BR ;
Miller, JS ;
Wagner, JE .
BLOOD, 2003, 102 (05) :1915-1919
[3]  
Cairo M, 2002, EXP HEMATOL, V30, P74
[4]   Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells [J].
Chao, NJ ;
Liu, CX ;
Rooney, B ;
Chen, BJ ;
Long, GD ;
Vredenburgh, JJ ;
Morris, A ;
Gasparetto, C ;
Rizzieri, DA .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (05) :249-256
[5]  
Deliliers GL, 1996, BONE MARROW TRANSPL, V18, P469
[6]   Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation [J].
Giralt, S ;
Thall, PF ;
Khouri, I ;
Wang, XM ;
Braunschweig, I ;
Ippolitti, C ;
Claxton, D ;
Donato, M ;
Bruton, J ;
Cohen, A ;
Davis, M ;
Andersson, BS ;
Anderlini, P ;
Gajewski, J ;
Kornblau, S ;
Andreeff, M ;
Przepiorka, D ;
Ueno, NT ;
Molldrem, J ;
Champlin, R .
BLOOD, 2001, 97 (03) :631-637
[7]   Outcome of cord-blood transplantation from related and unrelated donors [J].
Gluckman, E ;
Rocha, V ;
BoyerChammard, A ;
Locatelli, F ;
Arcese, W ;
Pasquini, R ;
Ortega, J ;
Souillet, G ;
Ferreira, E ;
Laporte, JP ;
Fernandez, M ;
Chastang, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :373-381
[8]  
Gluckman E, 1998, BONE MARROW TRANSPL, V22, pS68
[9]  
GUNJI Y, 1993, BLOOD, V82, P3283
[10]   T-cell recovery in adults and children following umbilical cord blood transplantation [J].
Klein, AK ;
Patel, DD ;
Gooding, ME ;
Sempowski, GD ;
Chen, BJ ;
Liu, CX ;
Kurtzberg, J ;
Haynes, BF ;
Chao, NJ .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (08) :454-466